Literature DB >> 19746183

MR imaging in endometrial carcinoma as a diagnostic tool for the prediction of myometrial invasion and lymph node metastasis.

Ui Nam Ryoo1, Chel Hun Choi, Ji Yeong Yoon, Soo Kyung Noh, Heeseok Kang, Woo Young Kim, Boh Hyun Kim, Tae-Joong Kim, Jeong-Won Lee, Je-Ho Lee, Byoung-Gie Kim, Duk-Soo Bae.   

Abstract

PURPOSE: The purpose of this study was to evaluate the factors that are associated with the accuracy of magnetic resonance (MR) imaging for predicting myometrial invasion and lymph node metastasis in women with endometrial carcinoma.
MATERIALS AND METHODS: We retrospectively reviewed the medical records and preoperative MR imaging reports of 128 women who had pathologically proven endometrial carcinoma. We compared the MR imaging and the histopathology findings.
RESULTS: The sensitivity, specificity and accuracy for identifing any myometrial invasion (superficial or deep) were 0.81, 0.61 and 0.74, respectively; these values for deep myometrial invasion were 0.60, 0.94 and 0.86, respectively. The sensitivity, specificity and accuracy of MR imaging for detecting lymph node metastasis were 50.0%, 96.6% and 93.0%, respectively. The patients who were older, had more deliveries and a larger tumor size more frequently had incorrect prediction of deep myometrial invasion (p=0.034, p=0.044, p=0.061, respectively). A higher tumor grade, a histology other than the endometrioid type, myometrial invasion on MR findings and a larger tumor size were associated with a more frequent false-negative prediction of lymph node metastasis (p=0.018, p=0.017, p=0.002, p=0.047, respectively). A larger tumor size was also associated with more frequent false-positive results (p=0.009).
CONCLUSIONS: There are several factors that make accurate assessment of myometrial invasion or lymph node metastasis difficult with using MRI; therefore, the patients with these factors should have their MR findings cautiously interpreted.

Entities:  

Keywords:  Accuracy; Endometrial carcinoma; MR imaging

Year:  2007        PMID: 19746183      PMCID: PMC2739369          DOI: 10.4143/crt.2007.39.4.165

Source DB:  PubMed          Journal:  Cancer Res Treat        ISSN: 1598-2998            Impact factor:   4.679


  24 in total

1.  Successful pregnancies in 2 infertile patients with endometrial adenocarcinoma.

Authors:  Yoshifumi Nakao; Mari Nomiyama; Kayoko Kojima; Yumi Matsumoto; Fumio Yamasaki; Tsuyoshi Iwasaka
Journal:  Gynecol Obstet Invest       Date:  2004-04-20       Impact factor: 2.031

2.  Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study.

Authors:  W T Creasman; C P Morrow; B N Bundy; H D Homesley; J E Graham; P B Heller
Journal:  Cancer       Date:  1987-10-15       Impact factor: 6.860

3.  Risk factors and recurrent patterns in Stage I endometrial cancer.

Authors:  P J DiSaia; W T Creasman; R C Boronow; J A Blessing
Journal:  Am J Obstet Gynecol       Date:  1985-04-15       Impact factor: 8.661

4.  Comparison of clinical and surgical-staging in patients with endometrial carcinoma.

Authors:  T A Cowles; J F Magrina; B J Masterson; C V Capen
Journal:  Obstet Gynecol       Date:  1985-09       Impact factor: 7.661

Review 5.  Endometrial carcinoma remaining after term pregnancy following conservative treatment with medroxyprogesterone acetate.

Authors:  J Mitsushita; T Toki; K Kato; S Fujii; I Konishi
Journal:  Gynecol Oncol       Date:  2000-10       Impact factor: 5.482

6.  MR imaging evaluation of endometrial carcinoma: results of an NCI cooperative study.

Authors:  H Hricak; L V Rubinstein; G M Gherman; N Karstaedt
Journal:  Radiology       Date:  1991-06       Impact factor: 11.105

7.  Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study.

Authors:  R C Boronow; C P Morrow; W T Creasman; P J Disaia; S G Silverberg; A Miller; J A Blessing
Journal:  Obstet Gynecol       Date:  1984-06       Impact factor: 7.661

8.  Prognosis and treatment of endometrial cancer.

Authors:  M L Berman; S C Ballon; L D Lagasse; W G Watring
Journal:  Am J Obstet Gynecol       Date:  1980-03-01       Impact factor: 8.661

9.  Myometrial invasion by endometrial carcinoma: assessment by MR imaging.

Authors:  S Sironi; G Taccagni; P Garancini; C Belloni; A DelMaschio
Journal:  AJR Am J Roentgenol       Date:  1992-03       Impact factor: 3.959

10.  Paraaortic lymph node evaluation in stage I endometrial carcinoma.

Authors:  M S Piver; S B Lele; J J Barlow; L Blumenson
Journal:  Obstet Gynecol       Date:  1982-01       Impact factor: 7.661

View more
  3 in total

1.  Feasibility of a reduced field-of-view diffusion-weighted (rFOV) sequence in assessment of myometrial invasion in patients with clinical FIGO stage I endometrial cancer.

Authors:  Priya Bhosale; Jingfei Ma; Revathy Iyer; Preetha Ramalingam; Wei Wei; Pamela Soliman; Michael Frumovitz; Vikas Kundra
Journal:  J Magn Reson Imaging       Date:  2015-07-16       Impact factor: 4.813

2.  Diagnostic Accuracy of Clinical Biomarkers for Preoperative Prediction of Lymph Node Metastasis in Endometrial Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Casper Reijnen; Joanna IntHout; Leon F A G Massuger; Fleur Strobbe; Heidi V N Küsters-Vandevelde; Ingfrid S Haldorsen; Marc P L M Snijders; Johanna M A Pijnenborg
Journal:  Oncologist       Date:  2019-06-11

3.  Magnetic resonance imaging pitfalls in determining myometrial invasion in stage I endometrial cancer: A case report and literature review.

Authors:  Hariyono Winarto; Muhammad Habiburrahman; Trifonia Pingkan Siregar; Kartiwa Hadi Nuryanto
Journal:  Radiol Case Rep       Date:  2022-05-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.